OXDERYS FDA approval date
The FDA approved OXDERYS on 9 Nov 2026.
- FDA approval date
- 9 Nov 2026
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as DOXORUBICIN HYDROCHLORIDE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2026-11-09Day | OXDERYS | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA221093", "applicant_as_listed_by_fda": "AVYXA HOLDINGS", "brand_names": ["OXDERYS"], "active_ingredients": ["DOXORUBICIN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20261109", "matched_on": "drug record created from this FDA brand name"} First seen: 16 Nov 2026 · Evidence last checked: 16 Nov 2026 |